DOD – Tuberous Sclerosis Complex Research Program – Full Application
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with unit
Memorial Deadline: Monday 29th, July 2024
External Deadline: Thursday 1st, August 2024
Description
The Tuberous Sclerosis Complex Research Program (TSCRP) released the following funding opportunities:
- Clinical Translational Research Award
- The CTRA supports studies that will move promising, well-founded preclinical and/or clinical
research findings closer to clinical application, including diagnosis, prognosis, or treatment of
TSC. - Exploration – Hypothesis Development Award
- The EHDA supports the initial exploration of innovative, high-risk, high-gain, and potentially
groundbreaking concepts in the TSC research field. The studies supported by this award
mechanism are expected to generate preliminary data for future avenues of scientific
investigation. The proposed research project should include a well-formulated, testable
hypothesis based on a strong scientific rationale and study design. Applications should
demonstrate the ability to achieve interpretable results in the absence of preliminary data
supporting the hypothesis. - Idea Development Award
- The IDA promotes ideas that have the potential to yield high-impact findings and new avenues
of investigation. This award mechanism supports conceptually innovative research that could
ultimately lead to critical discoveries in TSC research and/or improvements in patient care.
Research projects should include a well-formulated, testable hypothesis based on strong
preliminary data and scientific rationale.
To view the funding opportunity announcement and submit a pre-application visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=589101
Pre-Application (Letter of Intent) Submission Deadline: 5:00 p.m. Eastern time (ET),
June 12, 2024
Application Submission Deadline: 11:59 p.m. ET, August 1, 2024